Gardella J E, Ghiso J, Gorgone G A, Marratta D, Kaplan A P, Frangione B, Gorevic P D
Department of Pathology, State University of New York, Stony Brook.
Biochem Biophys Res Commun. 1990 Dec 31;173(3):1292-8. doi: 10.1016/s0006-291x(05)80927-1.
Using antibodies directed against N-terminal and C-terminal epitopes we have immunologically detected APP species in the membrane and saline-soluble fractions of unstimulated platelets, and in the conditioned medium of thrombin-stimulated platelets. These studies demonstrate an intact 140 kD membrane-associated form of APP that is released on degranulation. Evidence that platelets synthesize at least one form of APP (APP751) was obtained by enzymatic amplification of specific mRNA using Polymerase Chain Reaction (PCR) and direct sequence analysis of PCR product. Processing of APP for release may occur via successive C-terminal truncations, and/or by the release and proteolysis of an intact membrane associated form. An intact form of APP in platelets provides a circulating substrate upon which proteases from many tissues may act to produce beta protein (AB) during pathologic conditions.
我们使用针对N端和C端表位的抗体,在未刺激血小板的膜部分和盐溶性部分,以及凝血酶刺激血小板的条件培养基中,通过免疫方法检测到了APP种类。这些研究表明,存在一种完整的140 kD膜相关形式的APP,它在脱颗粒时被释放。通过使用聚合酶链反应(PCR)对特定mRNA进行酶促扩增以及对PCR产物进行直接序列分析,获得了血小板合成至少一种形式的APP(APP751)的证据。APP的释放加工可能通过连续的C端截短,和/或通过完整膜相关形式的释放和蛋白水解来进行。血小板中完整形式的APP提供了一种循环底物,在病理条件下,许多组织的蛋白酶可能作用于该底物以产生β蛋白(AB)。